Approvals/TGA/DEVA-AMOXYCLAV 400/57 amoxicillin 400mg (as trihydrate) and clavulanic acid 57mg (as potassium clavulanate) powder for oral suspension bottle

Approved

STANDARD

DEVA-AMOXYCLAV 400/57 amoxicillin 400mg (as trihydrate) and clavulanic acid 57mg (as potassium clavulanate) powder for oral suspension bottle

Devatis Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Date: May 29, 2025
Approval ID: bacf3a8c1185656b
Company: Devatis Pty Ltd
Type: Standard

Approval Details

Approval Id: bacf3a8c1185656b
Product Name: DEVA-AMOXYCLAV 400/57 amoxicillin 400mg (as trihydrate) and clavulanic acid 57mg (as potassium clavulanate) powder for oral suspension bottle
Artg Id: 216346
Artg Name: DEVA-AMOXYCLAV 400/57 amoxicillin 400mg (as trihydrate) and clavulanic acid 57mg (as potassium clavulanate) powder for oral suspension bottle
Sponsor: Devatis Pty Ltd
Company Detail Path: /organization/devatis-pty-ltd
Artg Date: 2014-12-15
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Product Information: https://medical-cdn.nocode.com/drug_tga/c4621752f1fc4c830c0bf75268e57b34.pdf

Active Ingredients

Approved

Quick Info

Agency

TGA

Country

🇦🇺

Approval Date

May 29, 2025

Approval ID

bacf3a8c1185656b

Type

Standard

Back to TGA Approvals